Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD.

Sci Rep · 2026 · PMC12901154 · PMID 41577954

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Although four patients in the poor control group showed a decreasing trend in serum IFN-λ3 levels from baseline, their absolute IFN-λ3 levels at 1 month remained high, with the lowest value being 65.9 pg/mL.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.